Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04743843
Other study ID # CD-0042
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 22, 2019
Est. completion date November 15, 2019

Study information

Verified date February 2021
Source Inspirata Europe Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study serves as a validation study for the Omnyx Dynamyx software and Hamamatsu .ndpi image file format, evaluating agreement of diagnosis between whole slide images (WSI) of the Omnyx system (Omnyx scanned .rts images and Omnyx Dynamyx software) and the Omnyx Dynamyx software with the Hamamatsu .ndpi images. The primary goal of this study is to demonstrate concordance between the two systems to validate the Omnyx Dynamyx software with the non-Omnyx .ndpi image file type.


Description:

The overall study design was to compare the diagnosis obtained by .rts WSI from the Omnyx system (Omnyx scanner and Omnyx Software) and diagnosis obtained by .ndpi WSI of the Hamamatsu S360 or similar scanner with the Omnyx Software. Pathologists read cases in the Omnyx Dynamyx software with .rts images from an Omnyx scanner and complete a Preliminary Surgical Pathology Consultant Report that includes a preliminary diagnosis. After a two-week washout period, the pathologists read the same cases in the Omnyx Dynamyx software with .ndpi images from a Hamamatsu scanner. The diagnosis from the Omnyx scanners are provided in the Final Surgical Pathology Consultant Report. Pathologists then complete an Inspirata Whole Slide Imaging Case Worksheet to determine confirmation of diagnosis - that is, agreement/concordance between the WSI from the two scanners. The study is designed to prove that the diagnosis of a case will be the same when using the Omnyx .rts file type as the Hamamatsu .ndpi file type regardless of tissue or procedure type. All discrepancies between the two "systems" will be documented and reconciled. Discrepancies categorized as Major or Minor. The Principal Investigator Discordance Review Form will be utilized to document the Principal Investigator's review of those cases where discrepancies were attributed to technical/technological aspects of WSI, such as sub-optimal image quality. This is a deidentified, retrospective study to evaluate surgical pathology cases, excluding frozen sections and cytology. Formalin-fixed paraffin embedded tissue from sixty (60) cases across a range of three (3) subspecialist categories will be used. Materials for each case include the original pathology report and the complete set of physical slides from each case at the time of diagnosis. Cases will be no more than two (2) years older than the Date of Protocol. The pathology reports will be deidentified and the key to match the pathology reports with the deidentified physical slides and deidentified Whole Slide Images (WSI) will be retained and managed by the Study Sponsor. Each slide will be scanned on the Omnyx VL120 scanner and Hamamatsu S360 scanner with 40x magnification settings and standard compression ratings for each system. Whole slide image data sets will be prepared by deidentified case number (for example, Case1- Case 60) and distributed to at least three (3) pathologists with any pertinent information about the case form the original pathology report EXCEPT the final diagnosis. Each of the approximately 60 cases will be read in both the Omnyx system with Omnyx .rts images and the Omnyx Dynamyx software with Hamamatsu .ndpi images with a two (2) week wash-out period between the .rts and .ndpi case reads. Each case will only be read once (by the same pathologist) in each of the two modalities. Therefore, if three (3) pathologists participate, each pathologist will be responsible for reading twenty (20) cases in both image formats. A pathologist will review all Omnyx .rts images first and record the preliminary diagnosis. The pathologist will then read the cases from the Hamamatsu .ndpi images in the Omnyx Dynamyx software and determine concordance between WSI produced by the Omnyx VL 120 scanner and viewed in the Omnyx Dynamyx software and images produced by the Hamamatsu S360 scanner and viewed in the Omnyx Dynamyx software. If the pathologist determines discordance, the PI will complete review of all discordant cases. Concordance will be reported by subspecialty and overall and will be reported between the original pathology report and the .rts images and the .rts images and the .ndpi images. Discordance must be significant as discerned by the adjudication pathologist. Minor discordance will be measured but only significant discordance will be reported as a primary endpoint of this study.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date November 15, 2019
Est. primary completion date November 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - • Approximately 60 surgical pathology cases (20 from each sub-specialty group): - Dermatopathology; - Breast; - Head and Neck • Slides that are no more than 2 years old Exclusion Criteria: - • Frozen sections; and - Cytology cases - Slides that require special non-brightfield optical considerations such as polarization or fluorescence - Hematology slides - Slides that require 60x or higher magnification (oil immersion)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Omnyx Dynamyx Software
Digital pathology image management and viewing software.

Locations

Country Name City State
United Kingdom Northern Lincolnshire and Goole NHS Foundation Trust Lincoln

Sponsors (1)

Lead Sponsor Collaborator
Inspirata Europe Ltd.

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concordance between digitized .rts images and digitized .ndpi images The proportion of diagnosis between Omnyx .rts images and Hamamatsu .ndpi images using Blyth-Still-Casella 95% confidence interval showed concordant diagnosis for each subspecialty and across all recommended subspecialties. 3 months
See also
  Status Clinical Trial Phase
Completed NCT03080623 - Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion
Completed NCT03073746 - Google Health Search Trial N/A
Recruiting NCT04568967 - TB-CAPT EXULTANT - HIV N/A
Completed NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy N/A
Completed NCT04168983 - Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy N/A
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Not yet recruiting NCT04035174 - Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa N/A
Recruiting NCT05043662 - UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
Recruiting NCT04056273 - Assess the Use of rEBUS With a Guide Sheath to Increase Transbronchial Lung Biopsy Yield Rate N/A
Completed NCT03193671 - Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis N/A
Recruiting NCT03210311 - Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema N/A
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Active, not recruiting NCT05185388 - Socioeconomic Inequalities in the Diagnosis and Treatment of Colon and Ovarian Cancer in England Between 2016-2017
Completed NCT04212286 - Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC N/A
Completed NCT04109625 - Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening N/A
Not yet recruiting NCT05064566 - Evaluation of Caries Detection Methods
Recruiting NCT03347630 - Pre-operative MRI of Esophagus Cancer N/A
Completed NCT05604482 - CXCR4-PET/CT for Diagnosing Giant Cell Arteritis N/A
Completed NCT04541160 - Ultra-low Dose Chest Computed Tomography: a Rule-out Tool for Community-acquired Pneumonia
Completed NCT04315207 - Breaking Potentially Bad News in Lung Cancer Workup: Telephone Versus In-person Breaking of Final Diagnosis N/A